Get the free FDA Guidelines for Nonproprietary Drug Names - gpo

This document outlines the responsibilities and guidelines for the naming of drugs by the U.S. Adopted Names Council, including cooperation with the FDA and the criteria for establishing drug names.

How to fill out fda guidelines for nonproprietary

How to fill out FDA Guidelines for Nonproprietary Drug Names

1. Review the FDA's guidance document on nonproprietary drug names to understand the requirements.
2. Identify the therapeutic class of the drug and determine if a recommended name already exists.
3. Ensure the proposed name is not misleading and doesn't suggest a specific use or efficacy.
4. Submit the proposed name to the FDA along with supporting data, including any relevant studies or evidence.
5. Wait for the FDA's feedback and be prepared to make adjustments based on their recommendations.

Who needs FDA Guidelines for Nonproprietary Drug Names?

1. Pharmaceutical companies developing new drugs.
2. Researchers and developers involved in drug formulation.
3. Regulatory affairs professionals responsible for drug approval processes.
4. Healthcare professionals needing clarity on drug naming conventions.

People Also Ask about

What is FDA non proprietary name guidance?

Under this naming convention, the nonproprietary name designated for each originator biological product, related biological product, and biosimilar product will be a proper name that is a combination of the core name and a distinguishing suffix that is devoid of meaning and composed of four lowercase letters.

What are the rules for naming drugs?

Quinlan shared some of those rules: It must use two syllables in the prefix. This will help distinguish the drug from others, and allows for more variety. It must avoid certain letters. It can't be considered marketing. It avoids medical terminology.

What are nonproprietary names for drugs?

International Nonproprietary Names (INN) identify pharmaceutical substances or active pharmaceutical ingredients. Each INN is a unique name that is globally recognized and is public property. A nonproprietary name is also known as a generic name.

What is the FDA guidance on established names?

Use of an established name, if there is one for a drug, is required by Section 502(e)(1) of the Act as information of the identity of a drug which may be distributed in different dosage forms under different brand or proprietary names by manufacturers or distributors.

What is a non proprietary name of a drug example?

Non-proprietary name is the name for the active ingredient in the medicine that is decided by an expert committee and is understood internationally (WHO, 2013a). Thus, paracetamol/acetaminophen is the non-proprietary name (generic name) while Crocin/Metacin/Meftal/Tylenol etc. are brand names.

What is an established name?

The official nonproprietary names of both drug substances and drug products are sometimes referred to as the established names (also compendial or pharmacopeial names) for an official article. These are “established” by appearing in the official pharmacopeia of a country (e.g., the United States Pharmacopeia; USP).

What is a drug established name?

The established name with respect to a drug product or ingredient thereof is the applicable official name designated pursuant to section 508 of the FD&C Act; or if there is no such official name, and such drug, or such ingredient, is an article recognized in an official compendium (such as the United States

What is the FDA 522 guidance?

Section 522 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) provides the Food and Drug Administration (FDA) with the authority to require manufacturers to conduct postmarket surveillance at the time of approval or clearance or at any time thereafter of certain class II or class III devices.

For pdfFiller’s FAQs

What is FDA Guidelines for Nonproprietary Drug Names?

The FDA Guidelines for Nonproprietary Drug Names provide a framework for the naming of drugs to ensure that the names are unique, non-confusing, and accurately reflect the chemical characteristics of the active ingredient.

Who is required to file FDA Guidelines for Nonproprietary Drug Names?

Pharmaceutical companies and manufacturers that wish to market a new drug or active pharmaceutical ingredient are required to file according to the FDA Guidelines for Nonproprietary Drug Names.

How to fill out FDA Guidelines for Nonproprietary Drug Names?

To fill out the FDA Guidelines, applicants should provide detailed information about the drug's active ingredient, proposed name, and reasoning for the name choice, ensuring compliance with naming conventions and avoiding confusion with existing names.

What is the purpose of FDA Guidelines for Nonproprietary Drug Names?

The purpose of the FDA Guidelines for Nonproprietary Drug Names is to facilitate safe prescribing and dispensing of medications by ensuring that drug names are clear and not misleading.

What information must be reported on FDA Guidelines for Nonproprietary Drug Names?

Information that must be reported includes the proposed nonproprietary name, chemical structure, pharmacological class, and any relevant safety data to support the name's uniqueness and appropriateness.